5.14
price up icon0.00%   0.00
after-market アフターアワーズ: 5.14
loading
前日終値:
$5.14
開ける:
$5.12
24時間の取引高:
167.76K
Relative Volume:
0.20
時価総額:
$232.74M
収益:
-
当期純損益:
$-32.74M
株価収益率:
-6.2683
EPS:
-0.82
ネットキャッシュフロー:
$-24.89M
1週間 パフォーマンス:
-0.39%
1か月 パフォーマンス:
+46.02%
6か月 パフォーマンス:
-60.91%
1年 パフォーマンス:
-50.86%
1日の値動き範囲:
Value
$5.12
$5.15
1週間の範囲:
Value
$5.08
$5.20
52週間の値動き範囲:
Value
$3.18
$16.94

Third Harmonic Bio Inc Stock (THRD) Company Profile

Name
名前
Third Harmonic Bio Inc
Name
セクター
Healthcare (1176)
Name
電話
(209) 727-2457
Name
住所
1700 MONTGOMERY STREET, SAN FRANCISCO
Name
職員
53
Name
Twitter
Name
次回の収益日
2025-03-26
Name
最新のSEC提出書
Name
THRD's Discussions on Twitter

THRD を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
THRD
Third Harmonic Bio Inc
5.14 232.74M 0 -32.74M -24.89M -0.82
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.84 125.74B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
602.64 61.57B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.76 36.40B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.56 30.36B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
244.90 24.89B 3.81B -644.79M -669.77M -6.24

Third Harmonic Bio Inc Stock (THRD) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-03-28 ダウングレード Stifel Buy → Hold
2025-02-12 ダウングレード Morgan Stanley Overweight → Equal-Weight
2025-02-11 ダウングレード Raymond James Outperform → Mkt Perform
2024-08-09 アップグレード Morgan Stanley Equal-Weight → Overweight
2024-06-18 開始されました Stifel Buy
2024-06-07 開始されました Raymond James Outperform
2022-12-16 ダウングレード Jefferies Buy → Hold
2022-12-15 ダウングレード Morgan Stanley Overweight → Equal-Weight
2022-10-10 開始されました Cowen Outperform
2022-10-10 開始されました Jefferies Buy
2022-10-10 開始されました Morgan Stanley Overweight
すべてを表示

Third Harmonic Bio Inc (THRD) 最新ニュース

pulisher
Apr 23, 2025

Third Harmonic Bio CSO steps down, enters separation agreement - Investing.com Australia

Apr 23, 2025
pulisher
Apr 23, 2025

Third Harmonic Bio’s CSO Christopher Dinsmore Steps Down - MSN

Apr 23, 2025
pulisher
Apr 22, 2025

Third Harmonic Bio CSO steps down, enters separation agreement By Investing.com - Investing.com South Africa

Apr 22, 2025
pulisher
Apr 18, 2025

New fund Alis offers struggling biotechs an off-ramp: Finance Report - BioCentury

Apr 18, 2025
pulisher
Apr 17, 2025

Finance Watch: Investors Push ESSA Pharma, Elevation Oncology To Wind Down - insights.citeline.com

Apr 17, 2025
pulisher
Apr 16, 2025

SF biotech company, once worth nearly $1 billion, plans to shut down - SFGATE

Apr 16, 2025
pulisher
Apr 16, 2025

Biotech Alert: Searches spiking for these stocks today - TipRanks

Apr 16, 2025
pulisher
Apr 16, 2025

Third Harmonic Bio (THRD) Plans Liquidation; Significant Search Surge in Biotech Sector | ARTL Stock News - GuruFocus

Apr 16, 2025
pulisher
Apr 15, 2025

Third Harmonic Bio (THRD) Seeks Stockholder Approval for Liquida - GuruFocus

Apr 15, 2025
pulisher
Apr 15, 2025

Third Harmonic Bio plans to liquidate the company, sell urticaria treatment - MSN

Apr 15, 2025
pulisher
Apr 15, 2025

Third Harmonic Bio, Inc. Liquidation and Shareholder Distribution: Analyst Maintains Hold Rating Amid Strategic Uncertainties - TipRanks

Apr 15, 2025
pulisher
Apr 15, 2025

Third Harmonic's shutdown, Coherus and Xoma drug sales connectedBizwomen - The Business Journals

Apr 15, 2025
pulisher
Apr 15, 2025

Third Harmonic Bio leaps as it reveals liquidation plan - The Pharma Letter

Apr 15, 2025
pulisher
Apr 15, 2025

Big moves by small biotechs signal potential shift for investorsSan Francisco Business Times - The Business Journals

Apr 15, 2025
pulisher
Apr 15, 2025

Top 3 Health Care Stocks You May Want To Dump This Quarter - Benzinga

Apr 15, 2025
pulisher
Apr 15, 2025

Fierce Biotech Layoff Tracker 2025: Mural lays off 90%; Pfizer sells site, cuts staff - Fierce Biotech

Apr 15, 2025
pulisher
Apr 15, 2025

Third Harmonic Bio Announces Liquidation Plan: Stock Skyrockets 39% Pre-Market, But Retail’s Shattered - MSN

Apr 15, 2025
pulisher
Apr 14, 2025

Third Harmonic Bio plans liquidation and asset sale By Investing.com - Investing.com South Africa

Apr 14, 2025
pulisher
Apr 14, 2025

$26bn Brighton Jones hires new CFO - Citywire

Apr 14, 2025
pulisher
Apr 14, 2025

Third Harmonic Bio, Apple, Dell And Other Big Stocks Moving Higher In Monday's Pre-Market Session (CORRECTED) - Benzinga

Apr 14, 2025
pulisher
Apr 14, 2025

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Apr 14, 2025
pulisher
Apr 14, 2025

Third Harmonic outlines plans for dissolution - BioPharma Dive

Apr 14, 2025
pulisher
Apr 14, 2025

Third Harmonic Bio sees initial distribution of $5.13-$5.33 from liquidation - TipRanks

Apr 14, 2025
pulisher
Apr 14, 2025

Third Harmonic Bio stock holds as liquidation plan unveiled By Investing.com - Investing.com Canada

Apr 14, 2025
pulisher
Apr 14, 2025

Third Harmonic Bio Stock Is Up 40% Monday: What's Happening?Third Harmonic Bio (NASDAQ:THRD) - Benzinga

Apr 14, 2025
pulisher
Apr 14, 2025

Third Harmonic Announces Liquidation And Cash Return, Stock Jumps - Nasdaq

Apr 14, 2025
pulisher
Apr 14, 2025

Third Harmonic to shutter; Future Pak once again targets Theratechnologies - Endpoints News

Apr 14, 2025
pulisher
Apr 14, 2025

THRD’s Ambitious Moves: From Trials to Strategies? - timothysykes.com

Apr 14, 2025
pulisher
Apr 14, 2025

Third Harmonic Bio Plans Liquidation With Lucrative Payouts - Finimize

Apr 14, 2025
pulisher
Apr 14, 2025

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Apr 14, 2025
pulisher
Apr 14, 2025

Third Harmonic Bio announces plan of liquidation and dissolution - TipRanks

Apr 14, 2025
pulisher
Apr 14, 2025

Third Harmonic Seeks to Liquidate, Dissolve Company - marketscreener.com

Apr 14, 2025
pulisher
Apr 14, 2025

Third Harmonic Bio Announces Plan Of Liquidation And Dissolution - marketscreener.com

Apr 14, 2025
pulisher
Apr 14, 2025

Third Harmonic Bio Announces Plan of Liquidation and Dissolution - The Manila Times

Apr 14, 2025
pulisher
Apr 14, 2025

Third Harmonic Bio plans liquidation and asset sale - Investing.com Australia

Apr 14, 2025
pulisher
Apr 14, 2025

Third Harmonic Bio to Return $255M to Shareholders in Major Cash Distribution - Stock Titan

Apr 14, 2025
pulisher
Apr 11, 2025

Layoff Tracker: Opthea Slashes 65% of Staff, Pfizer Cuts 56 - BioSpace

Apr 11, 2025
pulisher
Apr 07, 2025

Third Harmonic stock rating cut by Raymond James - MSN

Apr 07, 2025
pulisher
Mar 31, 2025

Third Harmonic Bio initiates process to identify opportunities to maximize value - TipRanks

Mar 31, 2025
pulisher
Mar 29, 2025

Hold Rating for Third Harmonic Bio, Inc. Amid Strategic Exploration and Cautious Development Approach - TipRanks

Mar 29, 2025
pulisher
Mar 29, 2025

Stifel Downgrades Third Harmonic Bio (THRD) - MSN

Mar 29, 2025
pulisher
Mar 28, 2025

Stifel Nicolaus Downgrades Third Harmonic Bio to Neutral From Buy, Adjusts Price Target to $5 From $23 - MarketScreener

Mar 28, 2025
pulisher
Mar 28, 2025

Third Harmonic Bio Reports 2024 Financial Results and Strategic Plans - TipRanks

Mar 28, 2025
pulisher
Mar 27, 2025

Third Harmonic Bio reports FY24 EPS ($1.09) vs. (78c) last year - TipRanks

Mar 27, 2025
pulisher
Mar 27, 2025

Stifel cuts Third Harmonic stock rating to hold, slashes target to $5 - Investing.com

Mar 27, 2025

Third Harmonic Bio Inc (THRD) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Third Harmonic Bio Inc (THRD) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Conner Edward R.
Chief Medical Officer
Nov 08 '24
Sale
15.00
2,117
31,755
0
BVF PARTNERS L P/IL
See Explanation of Responses
Oct 29 '24
Sale
14.30
1,000,000
14,300,000
176,692
Conner Edward R.
Chief Medical Officer
Oct 28 '24
Option Exercise
4.20
2,673
11,227
2,673
Conner Edward R.
Chief Medical Officer
Oct 28 '24
Sale
15.00
2,673
40,095
0
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
大文字化:     |  ボリューム (24 時間):